月K · MACD · 年ROE Monthly Trend · 美元
MACD(12,26,9)
MACD · 前复权口径
年ROE(每份年报一根整柱,柱宽 = 生效期:报告期 + 4 个月起)
加载中…
获利能力 Profitability (单位:美元)
| 指标 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2025中报 | 2026中报 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 净资产收益率(ROE) | - | 13.53% | 15.04% | 22.50% | 17.68% | 17.89% | 20.69% | 25.74% | 43.42% | 21.08% | 22.24% | 20.94% | 23.69% | 28.73% | 18.88% | 28.88% | 26.14% | 22.52% | 50.15% | 10.56% | 6.73% | 5.94% |
| 总资产收益率(ROA) | - | 8.40% | 9.21% | 14.18% | 12.34% | 11.95% | 13.12% | 14.36% | 23.02% | 12.20% | 12.63% | 10.30% | 13.57% | 16.14% | 11.38% | 17.68% | 18.35% | 14.98% | 31.98% | 7.84% | 5.12% | 4.49% |
| 毛利率 | 63.97% | 65.34% | 66.10% | 69.80% | 71.78% | 70.82% | 74.15% | 74.74% | 73.07% | 75.25% | 73.09% | 74.52% | 74.77% | 74.37% | 75.36% | 76.13% | 83.79% | 80.47% | 79.46% | 78.01% | 78.06% | 77.73% |
| 净利率 | 12.58% | 10.36% | 10.41% | 17.34% | 15.07% | 14.10% | 15.35% | 19.02% | 34.92% | 19.85% | 19.22% | 16.99% | 19.40% | 24.08% | 18.77% | 28.73% | 34.09% | 27.93% | 76.66% | 17.62% | 23.36% | 18.35% |
| 每股收益(EPS) | 2.23 | 1.97 | 2.31 | 2.04 | 1.92 | 2.07 | 2.54 | 1.74 | 3.81 | 2.30 | 2.67 | 2.77 | 1.15 | 1.68 | 1.32 | 2.41 | 2.46 | 2.31 | 6.98 | 1.84 | 1.18 | 1.08 |
财务结构 Financial Structure
| 指标 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2025中报 | 2026中报 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 现金占总资产比率 | - | 10.54% | 15.62% | 20.68% | 22.41% | 8.64% | 14.00% | 15.51% | 18.56% | 17.71% | 20.62% | 14.44% | 13.41% | 18.17% | 16.35% | 10.15% | 9.27% | 12.09% | 23.33% | 21.45% | 24.26% | 20.96% |
| 负债占总资产比率 | - | 37.92% | 37.24% | 28.33% | 25.97% | 32.45% | 33.41% | 43.01% | 37.80% | 38.29% | 41.93% | 47.83% | 41.01% | 36.06% | 36.79% | 31.36% | 29.98% | 28.24% | 22.92% | 24.53% | 21.37% | 22.66% |
经营能力 Operating Capability
| 指标 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2025中报 | 2026中报 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 应收账款周转率(次) | - | 7.51 | 6.05 | 4.86 | 4.78 | 5.23 | 5.47 | 6.76 | 8.07 | 7.91 | 8.11 | 7.83 | 8.15 | 8.00 | 8.52 | 8.99 | 6.94 | 6.49 | 8.93 | 9.20 | 4.23 | 4.40 |
| 平均收现日数 | - | 49 天 | 60 天 | 75 天 | 76 天 | 70 天 | 67 天 | 54 天 | 45 天 | 46 天 | 45 天 | 47 天 | 45 天 | 46 天 | 43 天 | 41 天 | 53 天 | 56 天 | 41 天 | 40 天 | 86 天 | 83 天 |
| 固定资产周转率(次) | - | 0.2091 | 0.1859 | 0.1907 | 0.1865 | 0.1813 | 0.1965 | 0.2061 | 0.1907 | 0.1935 | 0.1957 | 0.1979 | 0.2330 | 0.2439 | 0.3181 | 0.2956 | 0.3658 | 0.3176 | 0.3100 | 0.2986 | 0.5863 | 0.5434 |
| 总资产周转率 | - | 81.12% | 88.39% | 81.80% | 81.88% | 84.76% | 85.51% | 75.48% | 65.94% | 61.48% | 65.71% | 60.63% | 69.93% | 67.01% | 60.61% | 61.54% | 53.83% | 53.51% | 41.67% | 44.30% | 21.83% | 24.44% |
现金流量 Cash Flow (单位:亿美元)
| 指标 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2025中报 | 2026中报 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 现金及现金等价物 | - | 1.42 | 2.19 | 3.34 | 3.96 | 1.71 | 3.11 | 4.20 | 6.54 | 7.18 | 9.30 | 8.18 | 7.14 | 11.79 | 11.83 | 8.63 | 7.69 | 11.32 | 30.45 | 29.38 | 32.73 | 29.06 |
| 净利润 | 1.30 | 1.13 | 1.29 | 2.29 | 2.18 | 2.37 | 2.92 | 3.89 | 8.11 | 4.95 | 5.70 | 5.84 | 7.22 | 10.47 | 8.23 | 15.03 | 15.22 | 14.02 | 41.75 | 10.74 | 6.91 | 6.23 |
| 经营活动现金流量 | 2.33 | 2.13 | 1.53 | 1.65 | 2.51 | 3.14 | 3.62 | 4.73 | 10.22 | 5.50 | 7.04 | 10.01 | 9.27 | 11.83 | 10.54 | 17.32 | 12.18 | 8.96 | 5.42 | 15.95 | 5.71 | 6.96 |
| 投资活动现金流量 | -0.38 | -1.47 | 0.59 | 0.40 | -0.62 | -4.13 | -0.79 | -4.13 | -6.33 | -3.16 | -2.12 | -6.47 | 0.77 | -5.96 | -5.31 | -17.22 | 2.52 | 1.74 | 23.13 | -7.13 | -0.87 | -2.86 |
| 筹资活动现金流量 | -1.94 | -1.08 | -1.34 | -0.92 | -1.04 | -1.35 | -1.56 | 0.35 | -1.53 | -1.59 | -2.68 | -4.73 | -11.01 | -1.16 | -4.87 | -3.56 | -15.84 | -7.11 | -9.83 | -9.57 | -2.05 | -4.52 |
| 净现金流量 | 0.04 | -0.41 | 0.77 | 1.15 | 0.62 | -2.25 | 1.40 | 1.10 | 2.33 | 0.65 | 2.12 | -1.12 | -1.04 | 4.68 | 0.16 | -3.33 | -0.95 | 3.75 | 19.11 | -1.19 | 2.31 | -0.30 |
右侧两列为报告期累计口径同比(左:去年同期同一期次,右:最近一期季报,年报期次已在左侧列展示);周转率类指标为报告期累计值,未做年化。
医疗保健
- 近五年ROE对比
1
100.00%
PACS Group Inc
次新股
PACS
2
100.00%
ImmunityBio Inc
亏损年份
IBRX
3
100.00%
安进
AMGN
4
100.00%
奥洛兹美医疗
HALO
5
100.00%
Puma Biotechnology Inc
亏损年份
PBYI
6
100.00%
沃特世
WAT
7
100.00%
Picard Medical Inc
数据<5年
亏损年份
次新股
PMI
8
84.37%
IDEXX实验室
IDXX
9
79.94%
泰尼特保健
THC
10
74.93%
礼来
LLY
11
74.56%
诺和诺德
NVO
12
62.37%
BridgeBio Pharma Inc
亏损年份
BBIO
13
52.47%
硕腾
ZTS
14
50.94%
NRC Health
NRC
15
49.16%
Medpace Holdings Inc
MEDP
16
48.89%
葛兰素史克
GSK
17
32.44%
Harmony Biosciences Holdings In
HRMY
18
32.16%
Innoviva Inc
INVA
19
31.55%
强生
JNJ
20
30.84%
默沙东
MRK
21
30.27%
Chemed Corp
CHE
22
29.98%
InMode Ltd
INMD
23
28.48%
西佳科技
SIGA
24
27.65%
爱德华兹生命科学
EW
25
26.99%
诺华制药
NVS
26
25.87%
Catalyst Pharmaceuticals Inc
CPRX
27
24.94%
Molina Healthcare Inc
MOH
28
24.45%
再生元制药
REGN
29
24.38%
吉利德科学
GILD
30
24.35%
瑞思迈
RMD